Clinical Trials · NCT04904913
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Enrollment
- 328
- Start date
- Jun 2021
- Locations
- 1 site, China
- Primary endpoint
- Percent Change from Baseline in Body Weight